|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Carleton T. Garrett , Stewart SellPublisher: Humana Press Inc. Imprint: Humana Press Inc. Edition: Softcover reprint of the original 1st ed. 1995 Volume: 12 Dimensions: Width: 15.20cm , Height: 2.60cm , Length: 22.90cm Weight: 0.726kg ISBN: 9781617370007ISBN 10: 1617370002 Pages: 484 Publication Date: 17 September 2011 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsCh. 1. Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer.- Ch. 2. ras Proto-Oncogene Activation in Human Malignancy.- Ch. 3. C-myc as a Tumor Marker for Primary Human Cancers.- Ch. 4. p53 in Human Cancer.- Ch. 5. Oncogenes and Tumor-Suppressor Genes in Gynecological Malignancies.- Ch. 6. Genetic Alterations in Colon Cancer.- Ch. 7. Genetic Changes in Breast Cancer.- Ch. 8. Genetic Alterations in Lung Cancer.- Ch. 9. Wilms Tumor-Susceptibility Loci.- Ch. 10. Non-Hodgkin’s Lymphomas.- Ch. 11. Phenotypic Expression of Hodgkin’s Disease: Biologic, Immunologic, and Functional Properties of Reed-Sternberg Cells.- Ch. 12. Melanoma Markers.- Ch. 13. Detection of Minimal Residual Disease (MRD) in Leukemia and Lymphoma.- Ch. 14. P-Glycoproteins in Tumors.- Ch. 15. Genetically Engineered Antitumor Monoclonal Antibodies.- Ch. 16. Targeting Antisense Oligonucleotide Chemotherapy to the Type I Regulatory Subunit of cAMP-Dependent Protein Kinase.- Ch. 17. Summary and Perspective: Assessing Test Effectiveness—The Identification of Good Tumor Markers.ReviewsThe editors should be commended for attempting an extensive compilation of information on cancer markers...-New England Journal of Medicine Author InformationTab Content 6Author Website:Countries AvailableAll regions |